Mon, Jan 26, 2015, 6:57 AM EST - U.S. Markets open in 2 hrs 33 mins

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • mjrruby2000000 mjrruby2000000 Apr 19, 2013 2:01 PM Flag

    Would You Buy the Brooklyn Bridge?????.........

    If there was something inherently flawed with our Phase 2 trial, or data, and we presented it to the FDA, they would have simply said, NO. Rather they asked for further information.
    It's analogous, to someone asking if you would be interested in buying the Brooklyn Bridge. Would you say NO, or ask to see the last structural inspection?
    I believe the intention of the FDA is positive in nature.
    We were not invited by the FDA to attend the March meeting, rather Chris requested the meeting, to give us guidance as how to get our drug to these boys in dire need as quickly as possible. That's the point. The meeting was scheduled to provide "Guidance", nothing more. Not approval for AA, but simply guidance. That's is just what they got, and I believe it was very positive. It certainly shows that the small size of the trial is not a limiting factor for approval, as all the naysayers have pointed to, as the reason that the FDA would flatly turn us down.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
12.18-0.05(-0.37%)Jan 23 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.